首页> 外文期刊>European Journal of Pharmacology: An International Journal >The vascular response to the K+ channel inhibitor 4-aminopyridine in hypertensive rats.
【24h】

The vascular response to the K+ channel inhibitor 4-aminopyridine in hypertensive rats.

机译:高血压大鼠对K +通道抑制剂4-氨基吡啶的血管反应。

获取原文
获取原文并翻译 | 示例
           

摘要

The K+ channel inhibitor 4-aminopyridine induced an immediate increase in blood pressure and tension in spontaneously hypertensive rats (SHR). Further analysis strongly suggested this to be due to closure of vascular smooth muscle K+ channels, as previously concluded for normotensive rats (WKY). The tension response was greater in SHR than WKY, suggesting an increased channel activity in order to compensate for the high total peripheral vascular resistance in SHR. The response was enhanced after nitric oxide (NO) synthase inhibitor in both strains, probably reflecting increased channel activity after elimination of the NO-cGMP pathway. The response in SHR but not WKY was increased after alpha(1)-adrenoceptor inhibition and adrenalectomy but not sympathetic nerve transmitter depletion. It increased also after angiotensin AT(1) and endothelin ET(A) receptor antagonists and protein kinase C inhibitor. These results indicated an increased adrenal catecholamine, angiotensin AT(1) and endothelin ET(A) activation of the phospholipase C-protein kinase C pathway in SHR, inhibiting the 4-aminopyridine-sensitive K+ channels.
机译:K +通道抑制剂4-氨基吡啶诱导自发性高血压大鼠(SHR)的血压和张力立即升高。进一步的分析强烈表明,这是由于血管平滑肌K +通道的关闭所致,正如先前对降血压大鼠(WKY)得出的结论。 SHR中的张力反应大于WKY,表明通道活动增加,以补偿SHR中较高的总外周血管阻力。在两个菌株中,一氧化氮(NO)合酶抑制剂后,响应增强,可能反映了消除NO-cGMP途径后通道活性增加。 α(1)-肾上腺素受体抑制和肾上腺切除术但没有交感神经递质耗竭后,SHR中的反应增加,但WKY没有增加。在血管紧张素AT(1)和内皮素ET(A)受体拮抗剂和蛋白激酶C抑制剂作用后也增加。这些结果表明SHR中磷脂酶C蛋白激酶C途径的肾上腺儿茶酚胺,血管紧张素AT(1)和内皮素ET(A)激活增加,从而抑制了4-氨基吡啶敏感性K +通道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号